Two‐year outcomes of epicranial focal cortex stimulation in pharmacoresistant focal epilepsy

Documenti analoghi

• Add‐on treatment with cenobamate is already effective at low doses in refractory focal epilepsy: A prospective observational study
  di: Yulia Novitskaya, et al.
  Pubblicazione: (2024)
• Neuroanatomical correlates of neuropsychological dysfunction in pediatric pharmacoresistant epilepsy due to focal cortical dysplasia type II
  di: Ana Arenivas, et al.
  Pubblicazione: (2026)
• Recurrent c.‐11C>T change located upstream of the normal ATG initiation codon of ANKH causes self‐limited familial infantile epilepsy
  di: Josua Kegele, et al.
  Pubblicazione: (2025)
• Medial pulvinar stereoelectroencephalographic biomarkers associated with deep brain stimulation response in focal drug‐resistant epilepsy
  di: Ionuț‐Flavius Bratu, et al.
  Pubblicazione: (2025)
• Impact of cenobamate on cortical responses to transcranial magnetic stimulation in people with drug‐resistant focal epilepsy
  di: Silvano R. Gefferie, et al.
  Pubblicazione: (2026)